"10.1371_journal.pone.0087919","plos one","2014-02-03T00:00:00Z","Hiroki Sato; Victor Tuan Giam Chuang; Keishi Yamasaki; Noriyuki Yamaotsu; Hiroshi Watanabe; Kohei Nagumo; Makoto Anraku; Daisuke Kadowaki; Yu Ishima; Shuichi Hirono; Masaki Otagiri; Toru Maruyama","Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Center for Clinical Pharmaceutical Science, Kumamoto University, Kumamoto, Japan; School of Pharmacy, Curtin Health Innovation Research Institute, Curtin University, Perth, Australia; Faculty of Pharmaceutical Sciences, DDS Research Institute, Sojo University, Kumamoto, Japan; School of Pharmacy, Kitasato University, Tokyo, Japan","Conceived and designed the experiments: HS KY NY. Performed the experiments: HS. Analyzed the data: HS MA. Contributed reagents/materials/analysis tools: KN DK SH MO. Wrote the paper: VC HW YI MO TM.","The authors have the following interests. The human serum albumin for this study was a gift from Vaccine maker 'KAKETSUKEN', also known as the Chemo-Sero-Therapeutic Research Institute. There are no further patents, products in development or marketed products to declare. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","02","Hiroki Sato","HS",12,TRUE,3,1,2,5,TRUE,TRUE,FALSE,0,NA,FALSE
